RP-04340

N/A

Report date: 2025/06/26 09:45:22
NME

Base Information

Drug NameRP-04340
Drug Alias NameRP-04340
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionKRAS G12C degradersKRAS G12D degradersKRAS G12V degraders
TargetsKRAS G12CKRAS G12DKRAS G12V
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRisen(Shanghai) Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRisen(Shanghai) Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A